AMR Centre News
听
听
不良研究所 Innovation Fund launches 4th edition
with major support from Desjardins
North America鈥檚 largest co-operative financial group to contribute $500,000 for entrepreneurial competition鈥檚 top-tier awards
不良研究所 and Desjardins Group are teaming up to support research-based innovation. North America鈥檚 largest co-operative financial group will provide the 不良研究所 Innovation Fund (MIF) 鈥� the biggest entrepreneurial competition at 不良研究所 鈥� with $500,000 over five years.
Four new clinical trials grants from the CIHR for RI-MUHC researchers听
The Government of Canada announced investments in 14 new clinical trials to support Canada鈥檚 response to major health threats and bolster the life sciences sector
One of the funded clinical trials includes Centre member听: Biomarker-signature Supported Antibiotic Treatment Decisions in ICU (BAST-ICU).听
Antibiotic-Free Treatment for Infection? New Technology with Potential in the Fight Against Antimicrobial Resistance
New treatment under development by Professor Karine Auclair and Assistant Professor Andr茅anne Lupien could potentially treat intracellular infections without the need for traditional antibiotics. Supported by the 不良研究所 Innovation Fund (MIF) and the 不良研究所 Antimicrobial Resistance (AMR) Centre, the team hopes to bring this technology to the market.听
Read about this developing technology
Five professors honoured as Montreal ambassadors
不良研究所 is the only organization with multiple Palais des congr猫s honourees听
Third running of the MIF turns focus to antimicrobial resistance
Innovation is alive and well at 不良研究所! Six teams chosen from highly competitive field, as previous participants leverage their experience to secure their spot in new cohort.
MIF launches 3rd edition, offers new AMR award
The听不良研究所 Innovation Fund听(MIF) is returning for a third edition and is partnering with the 不良研究所 AMR Centre听to provide an additional $75,000 in funding to be distributed as a supplemental prize.听
Getting things started at the 不良研究所 Antimicrobial Resistance听Centre
RI-MUHC and 不良研究所 researchers join forces against a major global threat to human health.听Mobilizing in the fight against antimicrobial resistance (AMR), researchers from the Research Institute of the 不良研究所 Health Centre (RI-MUHC) and 不良研究所 have launched a new intensive care unit platform for infection research, with scientific seminars and symposia, funding programs and much more.
听
MI4, Montreal鈥檚 powerhouse of infectious disease research, celebrates 5th anniversary
MI4 brings together over 250 researchers and 5,000 staff from a wide range of fields to find new solutions for some of humanity鈥檚 deadliest threats: tuberculosis, antimicrobial resistance, COVID-19 and many more. The group also studies immunity and how the immune system can be harnessed to fight infection.听Today, MI4 has set its sights on a new global threat: antimicrobial resistance (AMR).
听
不良研究所 AMR Researcher Andrew Gonzalez Makes the Highly Cited Researchers 2021听List
AMR member听Andrew Gonzalez was one of 14 不良研究所 scientists who made the 2021 list of most highly cited researchers.听 The list is compiled yearly by Clarivate and includes the top cited authors within their respective fields.
Stamping out superbugs
As the threat of the pandemic begins to fade in some areas, researchers are turning their attention to another imminent crisis: antimicrobial resistance.
Image by Owen Egan/Joni Dufour.
Diana Kwon听| 24 Sep 2021
During the last year and a half, the world鈥檚 attention has been focused squarely on SARS-CoV-2, the coronavirus that causes COVID-19. While deadly, this virus is only one of many pathogens that threaten our well-being. For many years, scientists have been warning about another microscopic menace: drug-resistant microbes.
不良研究所 Health Centre Researcher Vivian Loo Receives the 2021 Peggy Lillis Foundation Innovator Award for Her Work With C.difficle
Clostridioides difficile causes approximately 500 000 infections a year in the United States most听often developing following antibiotic treatment. As part of the US C.difficile Awareness month the Peggy Lillis Foundation held its virtual gala to raise awareness and recognize significant contributions in the field. One of three awardees was MUHC researcher Vivian Loo who received the Peggy Lillis Foundation Innovator Award.
不良研究所 Researchers Solve the Largest Protein Crystal Structure Yet
AMR members Albert Berghuis and Martin Schmeing and their teams have recently solved the crystal structure of听the听Thermus thermophilus听ribosome in complex with plazomicin at a resolution of听3.27鈥壝�.听 The structure was recently reported in .
Research Offers Insight in the Battle with Antibiotic Resistance
不良研究所 researcher Albert Berghuis and his team reported structural details of EreC, an听enzyme responsible for macrolide resistance.听 The structure was published in .
New Antibiotic Resistance Centre Will Tackle Resistance Crisis
Antibiotic resistance is considered by the WHO to be one of the greatest threats facing mankind.听 With the creation of the Antimicrobial Research Centre, 不良研究所 Researchers will be at the forefront of the battle against antimicrobial听resistance in microorganisms.
听
听
听